Business Closely watched Janssen and Legend Biotech’s CAR-T cell therapy demonstrated durable responses in the earlier setting of Multiple Myeloma: Updated findings from the CARTITUDE-2 trial ByHaven smith August 9, 2022
Business Moderate and Severe Chronic Kidney Disease Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight ByHaven smith August 9, 2022
Business Mild To Moderate Plaque Psoriasis Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight ByHaven smith August 9, 2022
Business Wound Healing Devices Market Insights, Competitive Landscape, and Market Forecast by 2027 ByHaven smith August 9, 2022
Business Genmab/Abbvie’s Epcoritamab achieves a 100% response rate in patients with R/R follicular lymphoma (FL). Could safety issues be a concern? ByHaven smith August 8, 2022
Business Warts Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight ByHaven smith August 8, 2022
Business Venous Ulcer Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight ByHaven smith August 8, 2022
Business Gilead in trouble waters as Trodelvy shows below par response in 3L+ HR+/HER2- Breast Cancer Setting ByHaven smith August 5, 2022
